We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · March 29, 2021

Dose-Escalation Trial of Radiation Therapy and Concurrent Cisplatin for Stage II/III Triple-Negative Breast Cancer

International Journal of Radiation Oncology, Biology, Physics

 

Additional Info

International Journal of Radiation Oncology, Biology, Physics
A Phase I Dose-Escalation Trial of Radiation Therapy and Concurrent Cisplatin for Stage II and III Triple-Negative Breast Cancer
Int. J. Radiat. Oncol. Biol. Phys 2021 Mar 10;[EPub Ahead of Print], JR Bellon, YH Chen, R Rees, AG Taghian, JS Wong, RS Punglia, RY Shiloh, LEG Warren, MS Krishnan, J Phillips, J Pretz, R Jimenez, S Macausland, I Pashtan, C Andrews, SJ Isakoff, EP Winer, SM Tolaney

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading